# Datavault AI (DVLT) Grants Exclusive Worldwide License to Scilex for AI-Driven Biotech Exchange Platform

LOS ANGELES, CA - November 6, 2025 (NEWMEDIAWIRE) - Datavault AI (NASDAQ: DVLT), a leader in AI-driven blockchain solutions for data monetization and asset tokenization, has granted Scilex Holding Company an exclusive worldwide license to deploy its proprietary AI-driven technology within the biotech and biopharma sectors. The agreement enables Scilex to build and operate a Biotech Exchange platform to tokenize, trade, and monetize biotech assets such as genomic data, diagnostics, and drug information. Datavault AI expects the technology to expand into a Pharmaceutical Exchange platform addressing an estimated $2 trillion market opportunity, providing a path for companies to access non-dilutive funding. The deal includes a $10 million upfront payment in four installments and up to $2.55 billion in potential milestone payments, supported by Datavault AI’s broad patent portfolio and proven high-performance computing expertise.

 To view the full press release, visit https://ibn.fm/HAV6r

 About Datavault AI Inc.

 Datavault AI is leading the way in AI experience, valuation, and monetization of assets in the Web 3.0 environment. The company’s cloud-based platform provides comprehensive solutions with a collaborative focus in its Acoustic Science and Data Science Divisions. Datavault AI’s Acoustic Science Division features WiSA(R), ADIO(R) and Sumerian(R) patented technologies and industry first foundational spatial and multichannel wireless HD sound transmission technologies with IP covering audio timing, synchronization and multi-channel interference cancellation. The Data Science Division leverages the power of Web 3.0 and high-performance computing to provide solutions for experiential data perception, valuation and secure monetization. Datavault AI’s cloud-based platform provides comprehensive solutions serving multiple industries, including HPC software licensing for sports & entertainment, events & venues, biotech, education, fintech, real estate, healthcare, energy and more. The Information Data Exchange(R) (IDE) enables Digital Twins, licensing of name, image, and likeness (NIL) by securely attaching physical real-world objects to immutable metadata objects, fostering responsible AI with integrity. Datavault AI’s technology suite is completely customizable and offers AI and Machine Learning (ML) automation, third-party integration, detailed analytics and data, marketing automation and advertising monitoring. The company is headquartered in Beaverton, OR. Learn more about Datavault AI at www.datavaultsite.com.

 Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer

 Forward Looking Statements

 Certain statements in this article are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management's control, including the risks set forth under the heading "Risk Factors" discussed under the caption "Item 1A. Risk Factors" in Part I of the Company's most recent Annual Report on Form 10-K or any updates discussed under the caption "Item 1A. Risk Factors" in Part II of the Company's Quarterly Reports on Form 10-Q and in the Company's other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this article in making an investment decision, which are based on information available to us on the date hereof. All parties undertake no duty to update this information unless required by law 

---

[Original/Source Press Release](https://www.newmediawire.com/news/datavault-ai-dvlt-grants-exclusive-worldwide-license-to-scilex-for-ai-driven-biotech-exchange-platform-7083932)
                    

[Newsramp.com TLDR](https://newsramp.com/curated-news/datavault-ai-scilex-partner-on-2-55b-biotech-tokenization-deal/8aa2974903ff15afd82bf3e358ea0882) 

 

 



![Blockchain Registration](https://cdn.newsramp.app/newmediawire/qrcode/2511/6/blurmexD.webp)